A Pill for HIV Prevention: Déjà Vu All Over Again?
Authors:
Open Access
- 13 March 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 56 (11) , 1604-1612
Abstract
Recent FDA approval of tenofovir-emtricitabine for prevention of human immunodeficiency virus (HIV) as a form of pre-exposure prophylaxis (PrEP) has led to concern about implementation of this strategy. Fifty years ago, a very similar national and international debate occurred when the oral contraceptive pill (“the Pill” or “OCP”) was approved. Contentious issues included OCP safety, cost, and the potential impact on sexual behavior—many of the same concerns being voiced currently about PrEP. In this article, we review the social and medical history of OCP, drawing parallels with the current PrEP debate. We also explore the key areas where PrEP differs from its forbear: lower efficacy, presence of drug resistance, and a more circumscribed (and marginalized) target population. A thoughtful approach to PrEP implementation, bearing in mind the historical insights gained from the 1960s, might serve as well as we begin this new chapter in the control of the HIV epidemic.Keywords
This publication has 36 references indexed in Scilit:
- Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in BotswanaNew England Journal of Medicine, 2012
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and WomenNew England Journal of Medicine, 2012
- A US Policy Perspective on Oral Preexposure Prophylaxis for HIVAmerican Journal of Public Health, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010
- Knowledge and Use of HIV Pre-Exposure Prophylaxis Among Attendees of Minority Gay Pride Events, 2004JAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- The Abandoned Trials of Pre-Exposure Prophylaxis for HIV: What Went Wrong?PLOS Medicine, 2005
- Introduction of the pill and its impactContraception, 1999
- New Drug Shows Promise in MonkeysScience, 1995
- Prevention of SIV Infection in Macaques by ( R )-9-(2-Phosphonylmethoxypropyl)adenineScience, 1995
- THROMBOEMBOLISM AND ORAL CONTRACEPTIVERS: AN EPIDEMIOLOGIC CASE-CONTROL STUDY12American Journal of Epidemiology, 1969